Financhill
Back

ResMed Quote, Financials, Valuation and Earnings

ResMed Price Quote

$237.62
+0.35 (+2.61%)
(Updated: December 21, 2024 at 5:44 AM ET)

ResMed Key Stats

Sell
42
ResMed (RMD) is a Sell

Day range:
$231.00 - $238.60
52-week range:
$164.12 - $260.49
Dividend yield:
0.85%
P/E ratio:
34.29
P/S ratio:
7.28
P/B ratio:
6.7%

Volume:
2.8M
Avg. volume:
811.4K
1-year change:
36.39%
Market cap:
$34.8B
Revenue:
$4.7B
EPS:
$7.55

How Much Does ResMed Make?

Data Unavailable

Is ResMed Growing As A Company?

Data Unavailable

ResMed Stock Price Performance

  • Did ResMed Stock Go Up Last Month?
    ResMed share price went down by -1.77% last month
  • Did RMD's Share Price Rise Over The Last Year?
    RMD share price rose by 36.39% over the past 1 year

What Is ResMed 52-Week High & Low?

  • What Is ResMed’s 52-Week High Share Price?
    ResMed has traded as high as $260.49 over the past 52 weeks
  • What Is ResMed’s 52-Week Low Share Price?
    ResMed has traded as low as $164.12 over the past 52 weeks

ResMed Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ResMed?

Data Unavailable

Is ResMed Cash Flow Positive?

Data Unavailable

ResMed Return On Invested Capital

Data Unavailable

ResMed Earnings Date & Stock Price

  • What Is ResMed's Stock Price Today?
    A single share of RMD can be purchased today for 237.27
  • What Is ResMed’s Stock Symbol?
    ResMed trades on the nyse under the ticker symbol: RMD
  • When Is ResMed’s Next Earnings Date?
    The next quarterly earnings date for ResMed is scheduled on January 24, 2025
  • When Is RMD's next ex-dividend date?
    ResMed's next ex-dividend date is November 7, 2024
  • How To Buy ResMed Stock?
    You can buy ResMed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

ResMed Competitors

  • Who Are ResMed's Competitors?
    Below is a list of companies who compete with ResMed or are related in some way:
    • Boston Scientific Corp (BSX)
    • Globus Medical Inc (GMED)
    • Haemonetics Corp (HAE)
    • Merit Medical Systems Inc (MMSI)
    • Zimmer Biomet Holdings Inc (ZBH)

ResMed Dividend Yield

Data Unavailable

ResMed Analyst Estimates

YoY Growth Past Surprise
EPS: 41.61% 7.69%
Revenue: 11.09% 3.52%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 206.05
Downside from Last Price: -13.16%

Major Shareholders

Data Unavailable